BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17357998)

  • 21. Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection.
    Lotan Y; Shariat SF;
    BJU Int; 2008 Jun; 101(11):1362-7. PubMed ID: 18284410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpreting a study on bladder cancer screening.
    Inman BA; Abern MR
    Eur Urol; 2013 Jul; 64(1):48-50. PubMed ID: 23582948
    [No Abstract]   [Full Text] [Related]  

  • 23. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation.
    Cohn JA; Vekhter B; Lyttle C; Steinberg GD; Large MC
    Cancer; 2014 Feb; 120(4):555-61. PubMed ID: 24496869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fast measures in macro hematuria are both necessary and possible].
    Liedberg F; Holmäng S; Hosseini A; Ljungberg B; Malmström PU; Jahnson S
    Lakartidningen; 2012 May 14-29; 109(20-21):1034-5. PubMed ID: 22741410
    [No Abstract]   [Full Text] [Related]  

  • 25. Reply from authors re: Brant A. Inman, Michael R. Abern. Interpreting a study on bladder cancer screening. Eur Urol 2013;64:48-50: the goal of cancer screening: early evaluation of screening for bladder cancer.
    Roobol MJ; Bangma CH; Steyerberg EW
    Eur Urol; 2013 Jul; 64(1):50-1. PubMed ID: 23623479
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical forum: urological emergencies. Haematuria.
    Hadfield J
    Nurs Mirror; 1981 Jan; 152(4):suppl viii-xii. PubMed ID: 6906787
    [No Abstract]   [Full Text] [Related]  

  • 27. [Critical study of microscopic hematuria disclosed by screening tests].
    Giudicelli CP; Larroque P; Nedelec G; Talarmin F; Castanet F
    Ann Med Interne (Paris); 1984; 135(7):557-60. PubMed ID: 6393833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Case of the month: woman with hematuria and depressed mental status].
    Margretardottir OB; Geirsson G; Agnarsdottir M; Ulfarsson E
    Laeknabladid; 2012 Jul; 98(7-8):413-5. PubMed ID: 22947608
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinical utility of atypical cytology is significantly increased in both screening and monitoring for bladder cancer when indexed with nuclear matrix protein-22.
    Raina R; Pahlajani G; Ponsky LE; Agarwal A; Zippe CD
    BJU Int; 2008 Aug; 102(3):297-300. PubMed ID: 18702780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate and bladder cancer screening.
    Goldstein MM; Messing EM
    J Am Coll Surg; 1998 Jan; 186(1):63-74. PubMed ID: 9449601
    [No Abstract]   [Full Text] [Related]  

  • 31. Benefits of bladder-cancer screening at home.
    Susman E
    Lancet Oncol; 2006 Jul; 7(7):540. PubMed ID: 16838441
    [No Abstract]   [Full Text] [Related]  

  • 32. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
    Cha EK; Tirsar LA; Schwentner C; Hennenlotter J; Christos PJ; Stenzl A; Mian C; Martini T; Pycha A; Shariat SF; Schmitz-Dräger BJ
    World J Urol; 2012 Dec; 30(6):847-52. PubMed ID: 23124847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematuria: a problem-based imaging algorithm illustrating the recent Dutch guidelines on hematuria.
    van der Molen AJ; Hovius MC
    AJR Am J Roentgenol; 2012 Jun; 198(6):1256-65. PubMed ID: 22623537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of bladder carcinoma].
    Völter D; Keller AJ
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1304-5. PubMed ID: 6161771
    [No Abstract]   [Full Text] [Related]  

  • 35. Urothelial bladder cancer: biomarkers for detection and screening.
    Konety B; Lotan Y
    BJU Int; 2008 Nov; 102(9 Pt B):1234-41. PubMed ID: 19035887
    [No Abstract]   [Full Text] [Related]  

  • 36. Hematuria: definition and screening test methods.
    Higashihara E; Nishiyama T; Horie S; Marumo K; Mitarai T; Koyama T; Matsuyama T; Ito K; Yuno T;
    Int J Urol; 2008 Apr; 15(4):281-4. PubMed ID: 18380811
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fortuitous finding microhematuria].
    Fuchs VF; Altwein JE
    MMW Fortschr Med; 2005 Oct; 147(42):62-3. PubMed ID: 16281789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of colour blindness on recognition of haematuria in bladder cancer patients.
    Katmawi-Sabbagh S; Haq A; Jain S; Subhas G; Turnham H
    Urol Int; 2009; 83(3):289-90. PubMed ID: 19829027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex and the Diagnostic Pathway to Bladder Cancer among Veterans: No Evidence of Disparity.
    Lynch KE; Viernes B; Khader K; DuVall SL; Schroeck FR
    Womens Health Issues; 2020; 30(2):128-135. PubMed ID: 31870696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of hematuria referral to urologists: does a gender disparity exist?
    Johnson EK; Daignault S; Zhang Y; Lee CT
    Urology; 2008 Sep; 72(3):498-502; discussion 502-3. PubMed ID: 18619657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.